Pricing Log in Create free account
Friday 6 November 2026 Export LQDA’s income statement to Excel — free account

Liquidia Corporation

LQDA Healthcare Drug Manufacturers Specialty & Generic

Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.

Revenue
+1,842.7%
EPS
+271.4%
Free cash flow
+270.2%
Total debt
−9.04%

Quarter to June 2026, against a year earlier

44.69 2.69 −5.68%
Market cap
$4.0B
P/E
28.5×
Fwd P/E
22.1×
Dividend yield
—
F-score
5/9
Altman Z
4.08
Beneish M
6.79
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Liquidia Corporation (LQDA) Book value per share

Alert me on Book value per share

Liquidia Corporation's book value per share at the end of fiscal 2025 was 0.5×, down 48.4% from 1.0× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 2.2×. Over the past ten years it has ranged from −59.8× (fiscal 2017) to 2.6× (fiscal 2018); the current reading is higher than 25% of that period. Liquidia Corporation ranks 36th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 0.5× (48.44%)
FY2024 1.0× 38.59%
FY2023 0.7× (50.94%)
FY2022 1.5× 0.00%
FY2022 1.5× 12.90%
FY2021 1.3× 0.00%
FY2021 1.3× (37.37%)
FY2020 2.1× 0.00%
FY2020 2.1× 10.93%
FY2019 1.9× 0.01%

Quarterly newest first

Period Book value per share Change
Jun 2026 2.2× 77.91%
Mar 2026 1.2× 137.27%
Dec 2025 0.5× 103.60%
Sep 2025 0.3× 43.89%
32 more quarters

Against its own ten years

Low −59.8× High 2.6×
Ten-year median 1.4×
Current reading's percentile 25

Book value per share against peers

Company Book value per share
PBH Prestige Consumer Healthcare Inc. compare 40.9×
LNTH Lantheus Holdings, Inc. compare 20.8×
LQDA Liquidia Corporation 2.2×
AMLX Amylyx Pharmaceuticals, Inc. compare 2.2×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.6×
HIMS Hims & Hers Health, Inc. compare 1.4×
HCM HUTCHMED (China) Limited Sponsored ADR compare 0.0×
RGC Regencell Bioscience Holdings Limited compare 0.0×
SUPN Indivior Pharmaceuticals Inc. compare −0.5×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on LQDA